Status:
COMPLETED
Special Drug Use Investigation for LAMICTAL® (Long Term)
Lead Sponsor:
GlaxoSmithKline
Conditions:
Epilepsy
Eligibility:
All Genders
Brief Summary
The objectives of this post-marketing surveillance (PMS) are to grasp the actual use of lamotrigine tablets to collect safety information in the long-term use according to seizure type and concomitant...
Eligibility Criteria
Inclusion
- Subjects with epilepsy with partial seizures, tonic-clonic seizuresm or generalized seizures of Lennox-Gastaut syndrome
- Subjects who are treated with lamotrigine tablets
Exclusion
- None
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
850 Patients enrolled
Trial Details
Trial ID
NCT01863602
Start Date
April 1 2009
End Date
July 1 2016
Last Update
November 9 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.